Chimeric enters strategic manufacturing partnership with WuXi Advanced Therapies

MELBOURNE, Australia, April 11, 2022 (GLOBE NEWSWIRE) -- Chimeric Therapeutics (ASX:CHM, “Chimeric”) a clinical-stage cell therapy company and an Australian leader in cell therapy, is pleased to announce that it

Related Keywords

Australia ,California ,United States ,Melbourne ,Victoria ,Wuxi ,Jiangsu ,China ,Australian ,Jennifer Chow ,Matthew Wright ,David Chang ,Manufacturing Organisation ,Contract Testing Development ,University Of Pennsylvania ,City Of Hope Medical Centre ,Good Manufacturing Practice ,Wuxi Advanced Therapies ,Chimeric Therapeutics ,Wuxi Apptec ,Hope Medical Centre ,Neuroendocrine Tumours ,Jennifer Chow Chief Executive Officer ,Money ,Ational ,